Genvor Inc
GNVR· OTC
Filed May 13, 2026 · 10-Q · 43 days after period end · 0001903596-26-000213
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$429.57K | -$298.98K | -$772.06K | -$221.21K |
| EPS Diluted | -$0.01 | -$0.01 | -$0.04 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Genvor Inc · CIK 1792941 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end